George Fytas
- Organic Chemistry top 5%
- Molecular Biology
- Epidemiology top 10%
- Biochemistry top 5%
- Infectious Diseases
- Co-authors
- Nicolas KolocourisGeorge B. FoscolosErik De ClercqAntonios KolocourisJohan NeytsGrigoris ZoidisElizaveta PadalkoChristos Fytas
- Topics
- Pharmacological Receptor Mechanisms and Effects (13 papers)Eicosanoids and Hypertension Pharmacology (13 papers)Influenza Virus Research Studies (9 papers)
- Partner nations
- GreeceBelgiumUnited Kingdom
In The Last Decade
George Fytas
39 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 81
- Organic Chemistry 628
- Molecular Biology 389
- Epidemiology 336
- Biochemistry 153
- Infectious Diseases 80
Countries citing papers authored by George Fytas
This map shows the geographic impact of George Fytas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Fytas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Fytas more than expected).
Fields of papers citing papers by George Fytas
This network shows the impact of papers produced by George Fytas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Fytas. The network helps show where George Fytas may publish in the future.
Co-authorship network of co-authors of George Fytas
This figure shows the co-authorship network connecting the top 25 collaborators of George Fytas. A scholar is included among the top collaborators of George Fytas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Fytas. George Fytas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 25 | |
| 4 | 12 | |
| 5 | 35 | |
| 6 | 14 | |
| 7 | 84 | |
| 8 | 109 | |
| 9 | 28 | |
| 10 | 19 | |
| 11 | 127 | |
| 12 | 52 | |
| 13 | 55 | |
| 14 | 3 | |
| 15 | 45 | |
| 16 | 25 | |
| 17 | 16 | |
| 18 | 3-Cyclopentyl-1-adamantanamines and adamantanemethanamines. Antiviral activity evaluation and convulsions studies. | 4 |
| 19 | 100 | |
| 20 | 3 |
About George Fytas
George Fytas is a scholar working on Biochemistry, Organic Chemistry and Pharmaceutical Science, having authored 43 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacological Receptor Mechanisms and Effects (13 papers), Eicosanoids and Hypertension Pharmacology (13 papers) and Influenza Virus Research Studies (9 papers). The work is most often cited by research in Organic Chemistry (628 citations), Biochemistry (153 citations) and Epidemiology (336 citations). George Fytas has collaborated with scholars based in Greece, Belgium and United Kingdom. Frequent co-authors include Nicolas Kolocouris, George B. Foscolos, Erik De Clercq, Antonios Kolocouris, Johan Neyts, Grigoris Zoidis, Elizaveta Padalko, Christos Fytas, Lieve Naesens and John M. Kelly. Their work appears in journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.